Drugmaker Moderna (MRNA) is currently caught up in a major new development hitting drugmakers hard. This is especially true for drugmakers involved in making COVID-19 vaccines and treatments. The arrival of the new omicron variant of COVID-19 has caught drugmakers on the back foot. Moderna was already out in force suggesting that it may not have much of an impact against the new version of COVID-19. Despite Moderna's impressive place in pharmaceutical history, I remain bearish on the company as it sits. (See Analysts’ Top Stocks on TipRanks) Looking at Moderna's stock charts for the year so far shows a company whose best days may be behind it.
https://www.tipranks.com/news/article/moderna-takes-a-hit-against-omicron?utm_source=advfn.com&utm_medium=referral
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Moderna Charts.